Liquichek Tumor Marker Control

FDA 510(k) K141073 · Bio-Rad Laboratories

Substantially Equivalent

510(k) numberK141073

Submission

Device name
Liquichek Tumor Marker Control
Applicant
Bio-Rad Laboratories
Irvine, CA, US
Received
April 25, 2014
Decision date
June 23, 2014
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
JJY – Multi-Analyte Controls, All Kinds (Assayed)
Device class
Class I (low risk)
Regulation
21 CFR 862.1660
Specialty
Clinical Chemistry

Other 510(k)s with product code JJY

510(k)DeviceApplicantDecision
K162530Multichem IA PlusJJY · Abbreviated Techno-Path Manufacturing03/31/2017SE
K163629Audit MicroControls Linearity FD Tumor Markers IIJJY · Traditional Aalto Scientific, Ltd.03/10/2017SE
K163015Liquichek Tumor Marker Control-Level 1; Liquichek Tumor Marker Control-Level 2…JJY · Traditional Bio-Rad Laboratories01/10/2017SE
K153712VK-3 Verification Kit, VK-4 Verification Kit, VK-R5 Verification Kit, VK-R7 Verification…JJY · Traditional Radiometer America, Inc.01/28/2016SE
K150300Liquichek Cardiac Markers Plus Control LTJJY · Traditional Bio-Rad Laboratories12/11/2015SE
K142964VALIDATE Anemia Calibration Verification/ Linearity Test KitJJY · Traditional Maine Standards Company, LLC04/30/2015SE
K143379Liquichek Maternal Serum II ControlJJY · Traditional Bio-Rad Laboratories03/13/2015SE
K143573Audit MicroControls Linearity FD Tumor Markers IIJJY · Traditional Aalto Scientific, Ltd.01/16/2015SE
K140971Liquid Assayed Chemistry Control Premium Plus Level 1,2 and Level 3.JJY · Traditional Randox Laboratories Limited12/08/2014SE
K142978Audit MicroControls Linearity LQ Special DiabetesJJY · Traditional Aalto Scientific, Ltd.11/20/2014SE

More from Aalto Scientific, Ltd.

510(k)DeviceDecision
K183446BioPlex 2200 Lyme TotalLSR · Traditional 03/12/2019SE
K181661QXDx BCR-ABL %IS Kit for use on the QXDx AutoDG ddPCR SystemOYX · Traditional 02/13/2019SE
K180577BioPlex 2200 25-OH Vitamin D KitMRG · Traditional 06/22/2018SE
K171664Hemoglobin Variants System on Newborn Hemoglobin System with GDM and HbReview SoftwareGKA · Special 09/13/2017SE
K170509BioPlex 2200 ToRC IgM, BioPlex 2200 ToRC IgM Calibrator Set, BioPlex 2200 ToRC IgM…PUQ · Traditional 05/19/2017SE
K170413BioPlex 2200 Syphilis Total & RPR, BioPlex 2200 Syphilis Total & RPR Calibrator Set…LIP · Traditional 05/11/2017SE
K163015Liquichek Tumor Marker Control-Level 1; Liquichek Tumor Marker Control-Level 2…JJY · Traditional 01/10/2017SE
K161687D-10 Hemoglobin A1c ProgramPDJ · Traditional 10/14/2016SE
K152679Amplichek I, Negative , Amplichek I, Level 1, Amplichek I, Level 2, Amplichek I, Level…PMN · Traditional 05/10/2016SE
K150300Liquichek Cardiac Markers Plus Control LTJJY · Traditional 12/11/2015SE

Questions and answers

When was Liquichek Tumor Marker Control cleared by the FDA?

Liquichek Tumor Marker Control (K141073) received a 510(k) decision of Substantially Equivalent on June 23, 2014, 59 days after the submission was received.

What is the product code of K141073?

The FDA product code is JJY – Multi-Analyte Controls, All Kinds (Assayed), a Class I (low risk) device regulated under 21 CFR 862.1660.